Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Piccoli

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Biorxiv : the Preprint Server for Biology|June 9, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Nature|January 11, 2022
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, John E Bowen, Laura E Rosen, et al.
Biorxiv : the Preprint Server for Biology|December 21, 2021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, Christian Saliba, John E Bowen, et al.
Nature|July 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Nature|August 30, 2023
Neutralization, effector function and immune imprinting of Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Cell|February 23, 2021
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunityEmma C Thomson, Laura E Rosen, James G Shepherd, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Biorxiv : the Preprint Server for Biology|June 9, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Nature|January 11, 2022
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, John E Bowen, Laura E Rosen, et al.
Biorxiv : the Preprint Server for Biology|December 21, 2021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, Christian Saliba, John E Bowen, et al.
Nature|July 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Nature|August 30, 2023
Neutralization, effector function and immune imprinting of Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Cell|February 23, 2021
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunityEmma C Thomson, Laura E Rosen, James G Shepherd, et al.
Pageof 8